| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/07/2007 | EP1506211B1 C-aryl glucoside sglt2 inhibitors and method |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | CN1910201A Glucagon-like peptide-1 analogs with long duration of action |
| 02/07/2007 | CN1907949A Calcium receptor-active compounds |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298386C Prepn process of slow release parathyroid hormone microballoon |
| 02/07/2007 | CN1298377C Wheat seeding powder for preventing and treating insulin resisting syndrome and its preparation process |
| 02/07/2007 | CN1298319C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 02/07/2007 | CN1298313C Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173109 Peptide sequence derived from the ghrelin polypeptide, coupled to a cystine amino acid, labeled with a fluorescent dye; used in high throughput screening to identify and characterize cellular receptors |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173012 Hypoglycaemic peptides and methods of use thereof |
| 02/01/2007 | WO2006127932A3 Purification of cinacalcet |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027197 Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers |
| 02/01/2007 | US20070027128 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour |
| 01/31/2007 | EP1748048A1 Imidazopyridine compound |
| 01/31/2007 | EP1747231A1 Aminosulphonyl- or aminosulphonylamino-substituted phenyl esters as estriol and estetrol prodrugs |
| 01/31/2007 | EP1747230A1 Aminosulphonyl-or aminosulphonylamino-substituted phenyl esters as estradiol prodrugs |
| 01/31/2007 | EP1747229A1 Steroid prodrugs with androgenic effect |
| 01/31/2007 | EP1747182A2 Compounds with activity at estrogen receptor |
| 01/31/2007 | EP1746993A1 Controlled release metformin compositions |
| 01/31/2007 | EP1746982A2 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis and cardiovascular diseases |
| 01/31/2007 | CN1906207A Di-steroidal prodrugs of ethinyl estradiol |
| 01/31/2007 | CN1297269C Use of epothilone derivatives for the treatment of hyperparathyroidism |
| 01/31/2007 | CN1297253C Medicinal transferring system for intracephalic transference of medicine |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169769 17α-hydroxy-14β-steroids with hormonal effect |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7168597 Aerosol metering valve |
| 01/30/2007 | CA2394861C N6 heterocyclic 8-modified adenosine derivatives |
| 01/30/2007 | CA2266401C Use of sibutramine analogues to prevent the development of diabetes |
| 01/25/2007 | WO2007009913A1 Pyridazinone derivatives as thyroid hormone receptor agonists |
| 01/25/2007 | WO2007009383A1 A rectum suppository of protein and its preparation method and the use |
| 01/25/2007 | WO2007009194A1 Sra binding protein |
| 01/25/2007 | WO2006125642B1 Methods and apparatus for transdermal or transmucosal application of testosterone |
| 01/25/2007 | US20070021589 Obesity-related genes |
| 01/25/2007 | US20070021509 Phosphate transport inhibitors |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070020608 Method for the generation of neural progenitor cells |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | CA2612604A1 Purification of paricalcitol |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1745003A1 Novel compounds, their preparation and use |
| 01/24/2007 | EP1745002A1 Novel compounds, their preparation and use |
| 01/24/2007 | EP1744760A2 Pharmaceutical compositions for acute glucocorticoid therapy |
| 01/24/2007 | EP1744737A2 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1900079A New imidazole derivative, method for producing the same and use of the same |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/24/2007 | CN1899466A Insulin sensitivity enhancing medicinal composition |
| 01/24/2007 | CN1899251A Process for the semi-permanent shaping of the hair |
| 01/24/2007 | CN1899250A Application of biological active matteri-abric ketone cellulose and its dervivative |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/23/2007 | US7166608 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166461 Animal growth regulator |
| 01/23/2007 | US7166438 In Vitro screening for ligands of the estrogen receptor |
| 01/18/2007 | WO2007008157A1 New combination 2 |
| 01/18/2007 | WO2007008155A1 New combination 1 |
| 01/18/2007 | WO2007007149A1 Androgen modulators |
| 01/18/2007 | WO2006127941A3 Amorphous cinacalcet hydrochloride and preparation thereof |
| 01/18/2007 | WO2005070893A3 Azadecalin glucocorticoid receptor modulators |
| 01/18/2007 | US20070015778 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015714 Methods for treating FSH related conditions with GnRH antagonists |
| 01/18/2007 | US20070015687 Synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014818 Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol |
| 01/18/2007 | CA2610481A1 3-ester prodrugs of estradiol |
| 01/17/2007 | EP1743656A2 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
| 01/17/2007 | EP1742932A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor |
| 01/17/2007 | EP1742912A1 Novel androgens |
| 01/17/2007 | EP1742655A2 Use of ghrelin for the treatment of hyperthyroidism |
| 01/17/2007 | EP1742628A1 Alternative forms of the phosphodiesterase-4 inhibitor n-cyclopropyl-1-{3-¬(1-oxidopryidin-3-yl)ethynyl|phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide |
| 01/17/2007 | EP1482925B1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl]-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy |
| 01/17/2007 | EP1341793B1 Crf receptor antagonists and methods relating thereto |
| 01/17/2007 | EP1063990B1 Use of a biochanin-enriched extract for the treatment of estrogen-associated disorders |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/17/2007 | CN1895553A Chinese medicine for treating hyperthyroidism and its preparation |
| 01/17/2007 | CN1895269A Compound iodine oral solution quantitative drops and preparation thereof |
| 01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/11/2007 | WO2007005763A2 Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer |
| 01/11/2007 | WO2007005174A2 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists |
| 01/11/2007 | WO2007004390A1 Cachexia improving preparation and cachexia improving food |
| 01/11/2007 | WO2006125285B1 Insulin sensitization to slow down pubertal tempo and to augment pubertal growth |
| 01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/11/2007 | US20070010529 Nitrogenous heterocyclic compounds and medical use thereof |